Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-(chloromethyl)-N-methylbenzamide is a chemical compound with the molecular formula C9H10ClNO. It is a benzamide derivative characterized by the presence of a chloromethyl group and a methyl group attached to the nitrogen atom. 4-(chloromethyl)-N-methylbenzamide is primarily used in research and chemical synthesis, with ongoing studies to explore its properties and potential applications.

220875-88-7

Post Buying Request

220875-88-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

220875-88-7 Usage

Uses

Used in Research and Chemical Synthesis:
4-(chloromethyl)-N-methylbenzamide is utilized as a research chemical and intermediate in chemical synthesis for the development of new compounds and materials. Its unique structure allows for further functionalization and modification, making it a valuable building block in organic chemistry.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-(chloromethyl)-N-methylbenzamide is used as a potential candidate for drug discovery and development. Its chemical properties and reactivity may contribute to the design of new therapeutic agents, although further research is required to assess its efficacy, safety, and potential applications in medicine.
Used in Agrochemical Industry:
4-(chloromethyl)-N-methylbenzamide may also have potential applications in the agrochemical industry, where it could be used as a starting material or intermediate for the synthesis of new pesticides, herbicides, or other agrochemical products. Its reactivity and functional groups may offer advantages in the development of novel and effective agricultural chemicals.
Other Industrial Uses:
Beyond the pharmaceutical and agrochemical industries, 4-(chloromethyl)-N-methylbenzamide may find applications in other areas, such as materials science, where its unique structure could be leveraged to create new polymers or coatings with specific properties. However, further research is needed to fully understand its potential and safety profile in these applications.

Check Digit Verification of cas no

The CAS Registry Mumber 220875-88-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,8,7 and 5 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 220875-88:
(8*2)+(7*2)+(6*0)+(5*8)+(4*7)+(3*5)+(2*8)+(1*8)=137
137 % 10 = 7
So 220875-88-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H10ClNO/c1-11-9(12)8-4-2-7(6-10)3-5-8/h2-5H,6H2,1H3,(H,11,12)

220875-88-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(Chloromethyl)-N-methylbenzamide

1.2 Other means of identification

Product number -
Other names 4-(chloromethyl)-N-methyl-benzamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:220875-88-7 SDS

220875-88-7Relevant articles and documents

The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds with a chlorodifluoroethyl iodonium salt (CDFI)

Cao, Chengyao Kimmy,Chen, Chao,Ge, Chenxin,Niu, Yaru,Qu, Hongmei

supporting information, (2021/10/01)

Herein, we report a simple and efficient method for the direct installation of chlorodifluoroethyl group onto aromatic molecules of various aromatic amides with a new 2-chloro,2,2-difluoroethyl(mesityl)iodonium salt (CDFI). Moreover, the chlorodifluoroeth

INDOL AND INDAZOL DERIVATIVES

-

Page/Page column 69, (2015/04/15)

The present invention relates to indole and indazole derivatives of the following formula (I) wherein A is (AA) and the remaining variables are as defined in the specification. The compounds may be used for the treatment or prophylaxis of Alzheimer's disease, cognitive impairment, schizophrenia, pain or sleep disorders.

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES

-

Page/Page column 91, (2014/06/11)

The present invention provides compounds of formula I: [INSERT FORMULA HERE] or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.

NAPHTHYLACETIC ACIDS

-

Page/Page column 95-96, (2010/06/15)

The invention is concerned with the compounds of formula (I) and pharmaceutically acceptable salts and esters thereof, wherein X, Q, and R1-R6 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are antagonists or partial agonists at the CRTH2 receptor and may be useful in treating diseases and disorders associated with that receptor such as asthma.

N-Cycloalkanoyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists.

Sidduri, Achyutharao,Tilley, Jefferson W,Hull, Kenneth,Lou, Jian Ping,Kaplan, Gerry,Sheffron, Allen,Chen,Campbell, Robert,Guthrie, Robert,Huang, Tai-Nan,Huby, Nicholas,Rowan, Karen,Schwinge, Virginia,Renzetti, Louis M

, p. 2475 - 2478 (2007/10/03)

A systematic structure-activity relationship investigation of the lead compound 1 resulted the identification of several N-[(substituted alkyl)cycloalkanoyl]-4-[((2,6-dichlorophenyl)carbonyl)amino]-L-phenylalanine derivatives as potent VCAM/VLA-4 antagonists. The data are consistent with a model of these compounds in which these alkanoylphenylalanines reside in a compact gauche (-) bioactive conformation.

N-alkanoylphenylalanine derivatives

-

, (2008/06/13)

Compounds of the formula: are disclosed which have activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 220875-88-7